COR - Cencora, Inc.


286.74
2.300   0.802%

Share volume: 1,590,577
Last Updated: 04-17-2025
Wholesale/Wholesale – Drugs & Drug Proprietaries: 0.00%

PREVIOUS CLOSE
CHG
CHG%

$284.44
2.30
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
49%
Profitability 44%
Dept financing 36%
Liquidity 45%
Performance 59%
Company vs Stock growth
vs
Performance
5 Days
0.86%
1 Month
8.56%
3 Months
14.40%
6 Months
14.40%
1 Year
14.40%
2 Year
14.40%
Key data
Stock price
$286.74
P/E Ratio 
31.10
DAY RANGE
$281.65 - $287.84
EPS 
$2.52
52 WEEK RANGE
$248.11 - $296.65
52 WEEK CHANGE
$14.40
MARKET CAP 
43.426 B
YIELD 
0.93%
SHARES OUTSTANDING 
0.000
DIVIDEND
$0.55
EX-DIVIDEND DATE
02-14-2025
NEXT EARNINGS DATE
05-07-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,973,333
AVERAGE 30 VOLUME 
$2,098,032
Company detail
CEO: Steven H. Collis
Region: US
Website: www.cencora.com
Employees: 42,000
IPO year: 1995
Issue type:
Market: NYSE
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

Cencora, Inc. sources and distributes pharmaceutical products. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Recent news
loading